Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Filings indexed 1,320 across all filing types
Latest filing 2021-05-20 AGM Information
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA - Annual general meeting held
AGM Information Classification · 99% confidence The document text explicitly contains the heading 'PROTOKOLL FRA ORDINÆR GENERALFORSAMLING' (MINUTES FROM ANNUAL GENERAL MEETING) for 'PHOTOCURE ASA'. It details the proceedings, agenda items (like election of chairperson, approval of annual accounts, remuneration guidelines), and resolutions passed during the meeting held on May 20, 2021. This content perfectly matches the definition of AGM Information, which is classified as 'AGM-R'. Although it mentions the approval of the annual accounts (which might suggest a 10-K or AR), the document itself is the official record/minutes of the meeting where these items were discussed and voted upon.
2021-05-20 Norwegian
Photocure ASA - Annual general meeting held
AGM Information Classification · 98% confidence The document explicitly states that the 'Annual general meeting held' on May 20, 2021, and confirms that 'All proposals were resolved as presented'. It references the minutes of the general meeting being attached. This content directly relates to the proceedings and outcomes of the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is short and reports on the event rather than being the full presentation materials, but AGM-R covers presentations and materials shared during the AGM, which this announcement confirms the conclusion of.
2021-05-20 Norwegian
Photocure ASA - Annual general meeting held
AGM Information Classification · 98% confidence The document explicitly states that the 'Annual general meeting held' on May 20, 2021, and mentions that 'All proposals were resolved as presented in the notice convening the annual general meeting'. It concludes by stating that the minutes from the general meeting are 'attached hereto'. Since this is a short announcement confirming the holding of the AGM and referencing attached minutes, it falls under the category for materials shared during the Annual General Meeting, which is AGM-R (AGM Information). It is not the minutes themselves, but the announcement of the meeting's conclusion.
2021-05-20 English
Photocure ASA: Final grant of conditional share options
Director's Dealing Classification · 98% confidence The document details a transaction involving a 'person discharging managerial responsibilities' (CEO Daniel Schneider) concerning 'share options' granted by the issuer 'PHOTOCURE ASA'. This structure—reporting personal transactions by directors or executives regarding their holdings or options—is characteristic of insider trading disclosures. Reviewing the definitions, 'Director's Dealing' (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although this specific transaction is a grant of options rather than a sale/purchase of existing shares, it falls under the umbrella of mandatory disclosure of insider dealings/holdings changes. It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS) because it is highly specific to insider activity.
2021-05-19 English
Photocure ASA: Final grant of conditional share options
Remuneration Information Classification · 99% confidence The document announces the final grant and conversion of conditional share options to unconditional share options for several primary insiders (CEO, CFO, VPs) of Photocure ASA. It explicitly references 'Primary insider notifications pursuant to the market abuse regulation article 19' and 'disclosure requirements pursuant to the market abuse regulation article 19'. This type of filing, detailing personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing (DIRS). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it is highly specific to insider transactions.
2021-05-19 English
Photocure ASA: Final grant of conditional share options
Remuneration Information Classification · 99% confidence The document announces the final grant and conversion of conditional share options to unconditional share options for primary insiders (CEO, CFO, VPs) of Photocure ASA. This directly relates to personal share transactions by company directors and executives. This aligns perfectly with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). Although it mentions primary insider notifications are attached, the core content is the insider transaction disclosure itself, making DIRS the most specific fit over a general Regulatory Filing (RNS). The document length is short (2281 chars), but the content is the substance of the insider dealing, not just an announcement of a separate report.
2021-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.